PIM-1 kinase inhibitors(4SC Discovery/CRELUX)

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NamePIM-1 kinase inhibitors(4SC Discovery/CRELUX)
Drug Alias NamePIM kinase inhibitors(4SC Discovery)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionProto-oncogene serine/threonine-protein kinase Pim-1 inhibitors
TargetsProto-oncogene serine/threonine-protein kinase Pim-1
Therapy Area/IndicationsPulmonary Arterial HypertensionRespiratory Tract Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryGermany
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator Companies4SC Discovery Gmbh
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesCRELUX Gmbh4SC Discovery Gmbh
Active IndicationsN/A
Inactive IndicationsPulmonary Arterial HypertensionRespiratory Tract Diseases

Other Information

ATC CodeN/A
Related LinksN/A